| NDC包装代码 | 产品NDC | 产品类型 | 商品名 | 通用名 | 剂型 | 给药途径 | 上市日期 | 结束日期 | 市场类别 | 申请号 | 标签持有者 | 活性成分 | 规格 | 包装描述 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 68083-515-01 | 68083-515 | HUMAN PRESCRIPTION DRUG | Octreotide Acetate | Octreotide Acetate | INJECTION, SOLUTION | INTRAVENOUS; SUBCUTANEOUS | 20230613 | N/A | ANDA | ANDA216807 | Gland Pharma Limited | OCTREOTIDE ACETATE | 200 ug/mL | 1 VIAL in 1 CARTON (68083-515-01) / 5 mL in 1 VIAL |
| 68083-516-01 | 68083-516 | HUMAN PRESCRIPTION DRUG | Octreotide Acetate | Octreotide Acetate | INJECTION, SOLUTION | INTRAVENOUS; SUBCUTANEOUS | 20230613 | N/A | ANDA | ANDA216807 | Gland Pharma Limited | OCTREOTIDE ACETATE | 1000 ug/mL | 1 VIAL in 1 CARTON (68083-516-01) / 5 mL in 1 VIAL |